NCT02697201View on ClinicalTrials.gov

Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Insulin Resistance
Interventions
DRUG

Intralipid

0.55 ml/kg/h

DRUG

Saline

0.55 ml/kg/h for

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT02697201 - Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) | Biotech Hunter | Biotech Hunter